These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38326133)

  • 81. Effectiveness of systematic screening for the detection of atrial fibrillation.
    Moran PS; Flattery MJ; Teljeur C; Ryan M; Smith SM
    Cochrane Database Syst Rev; 2013 Apr; (4):CD009586. PubMed ID: 23633374
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Incident Atrial Fibrillation, Dementia and the Role of Anticoagulation: A Population-Based Cohort Study.
    Field TS; Weijs B; Curcio A; Giustozzi M; Sudikas S; Katholing A; Wallenhorst C; Weitz JI; Cohen AT; Martinez C
    Thromb Haemost; 2019 Jun; 119(6):981-991. PubMed ID: 30919384
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The incidence of atrial fibrillation and the use of warfarin in Northland, New Zealand stroke patients.
    Bang A; McGrath NM
    N Z Med J; 2011 Sep; 124(1343):28-32. PubMed ID: 21964010
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Severity and Etiology of Incident Stroke in Patients Screened for Atrial Fibrillation vs Usual Care and the Impact of Prior Stroke: A Post Hoc Analysis of the LOOP Randomized Clinical Trial.
    Diederichsen SZ; Frederiksen KS; Xing LY; Haugan KJ; Højberg S; Brandes A; Graff C; Olesen MS; Krieger D; Køber L; Svendsen JH
    JAMA Neurol; 2022 Oct; 79(10):997-1004. PubMed ID: 36036546
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Newly detected atrial fibrillation and compliance with antithrombotic guidelines.
    Glazer NL; Dublin S; Smith NL; French B; Jackson LA; Hrachovec JB; Siscovick DS; Psaty BM; Heckbert SR
    Arch Intern Med; 2007 Feb; 167(3):246-52. PubMed ID: 17296879
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Trends in the prevalence and management of pre-stroke atrial fibrillation, the South London Stroke Register, 1995-2014.
    Jain V; Marshall IJ; Crichton SL; McKevitt C; Rudd AG; Wolfe CDA
    PLoS One; 2017; 12(4):e0175980. PubMed ID: 28410424
    [TBL] [Abstract][Full Text] [Related]  

  • 87. New atrial fibrillation diagnosed perioperatively-anticoagulation practices in a secondary hospital.
    Kirby A; Jayathissa S
    N Z Med J; 2018 Mar; 131(1471):72-78. PubMed ID: 29518801
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Warfarin and Antiplatelet Therapy Versus Warfarin Alone for Treating Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement.
    Abdul-Jawad Altisent O; Durand E; Muñoz-García AJ; Nombela-Franco L; Cheema A; Kefer J; Gutierrez E; Benítez LM; Amat-Santos IJ; Serra V; Eltchaninoff H; Alnasser SM; Elízaga J; Dager A; García Del Blanco B; Ortas-Nadal Mdel R; Marsal JR; Campelo-Parada F; Regueiro A; Del Trigo M; Dumont E; Puri R; Rodés-Cabau J
    JACC Cardiovasc Interv; 2016 Aug; 9(16):1706-17. PubMed ID: 27539691
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Sex Differences in Oral Anticoagulation and Outcomes of Stroke and Intracranial Bleeding in Newly Diagnosed Atrial Fibrillation.
    Yong CM; Tremmel JA; Lansberg MG; Fan J; Askari M; Turakhia MP
    J Am Heart Assoc; 2020 May; 9(10):e015689. PubMed ID: 32394763
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Atrial Fibrillation Screen, Management And Guideline Recommended Therapy (AF SMART II) in the rural primary care setting: an implementation study protocol.
    Orchard JJ; Neubeck L; Freedman B; Webster R; Patel A; Gallagher R; Li J; Hespe CM; Ferguson C; Zwar N; Lowres N
    BMJ Open; 2018 Oct; 8(10):e023130. PubMed ID: 30385444
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Temporal trends in antithrombotic treatment of real-world UK patients with newly diagnosed atrial fibrillation: findings from the GARFIELD-AF registry.
    Apenteng PN; Gao H; Hobbs FR; Fitzmaurice DA;
    BMJ Open; 2018 Jan; 8(1):e018905. PubMed ID: 29331969
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Stepwise mass screening for atrial fibrillation using N-terminal pro b-type natriuretic peptide: the STROKESTOP II study design.
    Engdahl J; Svennberg E; Friberg L; Al-Khalili F; Frykman V; Kemp Gudmundsdottir K; Fredriksson T; Rosenqvist M
    Europace; 2017 Feb; 19(2):297-302. PubMed ID: 28011798
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Leveraging the electronic medical record to implement an abdominal aortic aneurysm screening program.
    Hye RJ; Smith AE; Wong GH; Vansomphone SS; Scott RD; Kanter MH
    J Vasc Surg; 2014 Jun; 59(6):1535-42. PubMed ID: 24507825
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Ethnic disparities in incidence of stroke subtypes: Auckland Regional Community Stroke Study, 2002-2003.
    Feigin V; Carter K; Hackett M; Barber PA; McNaughton H; Dyall L; Chen MH; Anderson C;
    Lancet Neurol; 2006 Feb; 5(2):130-9. PubMed ID: 16426989
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Detected atrial fibrillation in north Italy: rates, calculated stroke risk and proportion of patients receiving thrombo-prophylaxis.
    Filippi A; Bettoncelli G; Zaninelli A
    Fam Pract; 2000 Aug; 17(4):337-9. PubMed ID: 10934184
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Stroke associated with atrial fibrillation--incidence and early outcomes in the north Dublin population stroke study.
    Hannon N; Sheehan O; Kelly L; Marnane M; Merwick A; Moore A; Kyne L; Duggan J; Moroney J; McCormack PM; Daly L; Fitz-Simon N; Harris D; Horgan G; Williams EB; Furie KL; Kelly PJ
    Cerebrovasc Dis; 2010; 29(1):43-9. PubMed ID: 19893311
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The costs of warfarin underuse and nonadherence in patients with atrial fibrillation: a commercial insurer perspective.
    Casciano JP; Dotiwala ZJ; Martin BC; Kwong WJ
    J Manag Care Pharm; 2013 May; 19(4):302-16. PubMed ID: 23627576
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Digital recruitment and compliance to treatment recommendations in the Norwegian Atrial Fibrillation self-screening pilot study.
    Sandberg EL; Halvorsen S; Berge T; Grimsmo J; Atar D; Leangen Grenne B; Jortveit J
    Eur Heart J Digit Health; 2024 May; 5(3):371-378. PubMed ID: 38774377
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Negotiating a competitive speciality programme interview-a Māori clinician perspective.
    Martis WR; Alexander Z
    N Z Med J; 2024 Apr; 137(1593):90-92. PubMed ID: 38603792
    [No Abstract]   [Full Text] [Related]  

  • 100. The Prevalence and Management of Atrial Fibrillation in New Zealand Māori Detected through an Abdominal Aortic Aneurysm Screening Program.
    Sandiford P; Poppe KK; Grey C; Doughty R; Chambers E; Kim KJ; Hill A; Bartholomew K
    Heart Lung Circ; 2024 Mar; 33(3):304-309. PubMed ID: 38326133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.